Skip to main content
. 2021 Jan 6;11(1):e038677. doi: 10.1136/bmjopen-2020-038677

Table 5.

Time and events of work package IV

Screening Work package IV
Day −5 Day 0 Day 7
Enrolment Informed consent X
In/exclusion criteria X
Objective examination X
Safety outcomes Standard blood samples X
Primary outcome GI symptom questionnaires X X
Secondary outcomes MRI scan of brain and GI tract X
Continuous glucose monitoring graphic file with name bmjopen-2020-038677ilf05.jpg
Holter monitoring graphic file with name bmjopen-2020-038677ilf06.jpg
Sudomotor function X
Cardiovascular reflexes X
Inflammation markers X
Cardiac vagal tone X
Resting EEG X
QST X
GI transit graphic file with name bmjopen-2020-038677ilf07.jpg
Autonomic function questionnaire X

EEG, electroencephalography; GI, gastrointestinal; QST, quantitative sensory testing.